ANIP

ANI PHARMACEUTICALS, INC

ANIP · CIK 1023024 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$883M
20182025
Net Income$78M
20182025
Operating CF$185M
20182025
Free Cash Flow$171M
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$0.9B$0.6B$0.5B$0.3B$0.2B$0.1B$0.0B$0.1B
Cost of Revenue—————$0.1B$0.1B$0.1B
Gross Profit————————
R&D Expense$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
SG&A Expense$0.3B$0.2B$0.2B$0.1B$0.1B$0.1B$0.1B$0.0B
Operating Income$0.1B$0.0B$0.0B$-0.0B$-0.0B$0.0B$-0.0B$0.0B
Net Income$0.1B$-0.0B$0.0B$-0.0B$-0.0B$-0.0B$0.0B$0.0B
EPS (Basic)$3.50$-1.04$0.86$-3.05$-3.40$-0.30$-0.41$0.46
EPS (Diluted)$3.32$-1.04$0.85$-3.05$-3.40$-0.30$-0.41$0.46

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$1.4B$1.3B$0.9B$0.8B$0.8B$0.5B$0.5B$0.4B
Current Assets$0.8B$0.5B$0.5B$0.3B$0.3B$0.2B$0.2B$0.2B
Cash & Equivalents$0.3B$0.1B$0.2B$0.0B$0.1B$0.0B$0.1B$0.0B
Total Liabilities$0.9B$0.9B$0.4B$0.4B$0.4B$0.3B$0.2B$0.2B
Current Liabilities$0.3B$0.2B$0.1B$0.1B$0.1B$0.1B$0.1B$0.2B
Stockholders' Equity$0.5B$0.4B$0.4B$0.3B$0.3B$0.2B$0.2B$0.2B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$0.2B$0.1B$0.1B$-0.0B$0.0B$0.0B$0.0B$0.1B
Investing Cash Flow$-0.0B$-0.4B$-0.0B$-0.0B$-0.1B$-0.1B$-0.0B$-0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$-0.0B$0.3B$0.1B$-0.0B$0.2B$-0.0B$0.0B$-0.0B
← Companies